Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Nest Genomics
AddedFeb 15, 2024
UpdatedJul 3, 2026
Nest Genomics

Nest Genomics

Seed

Nest Genomics: Comprehensive genomic software for clinical care integration and management.

HQ
New York City, NY, US
Founded
2022
Accelerator
Y Combinator logoY CombinatorW22
Overview
Compare
Fundraising
Employees
Website

Nest Genomics was founded to revolutionize the integration of genetic data into clinical care. The company's core mission is to provide a comprehensive, lab-agnostic software solution that enables healthcare organizations to launch and manage large-scale genomic programs. Their platform supports the entire workflow, from patient triage, consent, and counseling for genetic testing to EMR-integrated clinical decision support and ongoing patient management. Nest Genomics focuses on delivering scalable genomic solutions across various medical specialties to enhance patient care quality.

Notable affiliated individuals and investors include leading experts in genomics and healthcare technology, although specific names are not disclosed. Key achievements of Nest Genomics include the successful deployment of their platform in multiple healthcare settings, demonstrating significant improvements in patient outcomes and operational efficiency. The overall impact of Nest Genomics lies in its ability to democratize access to genomic data, enabling personalized medicine and fostering a more proactive approach to healthcare.

Nest Genomics - Similar Companies

Gencove logo

Gencove

gencove.com

GenomeNext logo

GenomeNext

Navipoint Genomics logo

Navipoint Genomics

Genomenon logo

Genomenon

genomenon.com

General Genomics logo

General Genomics

ggenomics.com

Streamline Genomics logo

Streamline Genomics

Genome Medical logo

Genome Medical

genomemedical.com

Nucleus logo

Nucleus

Genome Insight logo

Genome Insight

Probably Genetic logo

Probably Genetic

WhiteLab Genomics logo

WhiteLab Genomics

whitelabgx.com

GenomOncology logo

GenomOncology

genomoncology.com

Genomelink logo

Genomelink

genomelink.io

Data Driven Bioscience logo

Data Driven Bioscience

Basepair logo

Basepair

basepairtech.com

Nest Genomics - Quick Facts

Who are Nest Genomics' competitors?

Companies similar to Nest Genomics include Gencove, GenomeNext, Navipoint Genomics and Genomenon.

When was Nest Genomics founded?

Nest Genomics was founded in 2022.

Where is Nest Genomics' headquarters located?

Nest Genomics' headquarters is located in New York City, NY, US.

When was Nest Genomics' last funding round?

Nest Genomics' most recent funding round was for $8.5M (USD) in January 2023.

How much has Nest Genomics raised to-date?

As of Jan 10, 2023, Nest Genomics has raised a total of $9M (USD).

How many employees does Nest Genomics have?

Nest Genomics has 12 employees as of Feb 4, 2024.

Nest Genomics - Classification

Ownership
  • Venture Capital
Technology
  • Software
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Genomics Software
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software